GLIOSARCOMA - A rare but aggressive tumour - Report of 2 cases
Journal: University Journal of Medicine and Medical Specialities (Vol.5, No. 3)Publication Date: 2019-05-30
Authors : MANIK VISHAL DEVKISHEN;
Page : 56-57
Keywords : Gliosarcoma; Aggressive Glioma; Temozolamide; GFAP and Vimentin.;
Abstract
Gliosarcoma is a rare malignant tumour of central nervous system presenting in the middle age group population. It has a biphasic histopathologic pattern with neural mesenchymal elements. Prognosis is poor. Here we report two cases treated at our department.Case description - Both patients were diagnosed with histopathology from surgically excised specimen. Immunohistochemistry reporting was done for confirmation. They were prescribed 60Gy radiation with concurrent Temozolamide 100mg daily till completion of radiation. Post radiation films showed gliotic changes only. Adjuvant Temozolamide was continued for 3 cycles as 150 mgm2 body surface area for days 1-5 q28 days. Further chemotherapy was discontinued as there was worsening to Karnofsky performance scale 40. Follow up scans were suggestive of progression. Patients were then put on supportive care.Conclusion - Gliosarcoma is a rare, aggressive variant of GBM. In spite of definitive treatment measures, progression is certain with worsening of symptoms.
Other Latest Articles
- Alveoloar Rhabdomyosarcoma in an adult presenting as a sino-orbital mass - a case report
- A RARE CASE REPORT - CAVERNOUS HAEMANGIOMA OF THE OPTIC NERVE HEAD
- ACUTE RETROBULBAR HAEMORRHAGE IN HEMOPHILIA
- Late presentation of Femoral head fracture treated with Herbert screws by safe surgical dislocation - A case report
- MANAGEMENT OF PAEDIATRIC SUBTROCHANTERIC FRACTURE WITH PAEDIATRIC DYNAMIC HIP SCREW-A CASE REPORT
Last modified: 2019-05-30 20:40:11